Updated preliminary data from the ongoing Phase Ib FRIDA trial evaluating iadademstat in combination with gilteritinib in FLT3-mutated relapsed/refractory AML showed a 67% response rate in the ...

Thermal validation underpins reliable cold-chain packaging, proving performance so teams protect products, cut waste and ...

The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.

ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that ...

Generative AI tools are putting a new spin on the age-old chore of writing and consuming technical documentation. The key is ...

Pharma marketing is shifting from a product-centered approach to one driven by data and engagement, according to Kamya Elawadhi, chief client officer at Doceree. In an interview with Fierce Pharma ...

Herantis Pharma announces positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease Trial meets all primary and secondary endpoints establishing a strong ...

Oct 1 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab, Takeda Pharmaceuticals (4502.T), opens new tab and Astex Pharmaceuticals are coming together to share proprietary data for training an ...

LEO Pharma A/S, a global leader in medical dermatology, today announced a late-breaking post hoc analysis of the European Academy of Dermatology and Venereology (EADV) Congress in Paris. The results ...

Daphne Koller, founder and CEO of Insitro, has secured major partnerships with pharmaceutical giants like Eli Lilly and Bristol Myers Squibb to advance A.I.-powered drug discovery. Courtesy of Insitro ...

Not only are billions of dollars of pharmaceutical direct-to-consumer TV/CTV advertising dollars at risk from the Trump Administration’s recent effort to stop DTC advertising, but major “pricing ...